Northern Trust’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Northern Trust's MXCT Position: Q2 2026 in Review
Northern Trust reduced its MaxCyte (MXCT) stake by 67% in Q2 2026, selling an estimated $533K and leaving 264,914 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3779.
Northern Trust first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $7.15M in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Northern Trust held 264,914 shares of MaxCyte worth $326K as of Q2 2026.
- Northern Trust sold 534,795 MaxCyte shares in Q2 2026, an estimated $533K.
- MaxCyte made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3779 holding.
- Northern Trust first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
- Northern Trust's MaxCyte position peaked at $7.15M in Q4 2021.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.